150 related articles for article (PubMed ID: 15130535)
1. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
Sergerie Y; Boivin G
J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
[TBL] [Abstract][Full Text] [Related]
3. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
[TBL] [Abstract][Full Text] [Related]
4. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
5. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
6. Antiviral drug susceptibility of human herpesvirus 8.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.
Bounaadja L; Piret J; Goyette N; Boivin G
J Clin Microbiol; 2013 Apr; 51(4):1244-6. PubMed ID: 23325820
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
12. Cidofovir on HHV-8 in BCBL-1 cells.
Pica F; Serafino A; Garaci E; Volpi A
Antivir Ther; 2004 Oct; 9(5):823-5. PubMed ID: 15535421
[No Abstract] [Full Text] [Related]
13. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
[TBL] [Abstract][Full Text] [Related]
14. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of porcine cytomegalovirus to antiviral drugs.
Fryer JF; Griffiths PD; Emery VC; Clark DA
J Antimicrob Chemother; 2004 Jun; 53(6):975-80. PubMed ID: 15117919
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay.
De Bolle L; Balzarini J; De Clercq E; Naesens L
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):999-1001. PubMed ID: 14565330
[No Abstract] [Full Text] [Related]
18. Value of animal models to evaluate agents with potential activity against human cytomegalovirus.
Kern ER
Transplant Proc; 1991 Jun; 23(3 Suppl 3):152-5, discussion 155. PubMed ID: 1648821
[No Abstract] [Full Text] [Related]
19. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
Yao GQ; Grill S; Egan W; Cheng YC
Antimicrob Agents Chemother; 1993 Jul; 37(7):1420-5. PubMed ID: 8395789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
